Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

Your search for ‘Patterson Belknap Webb & Tyler LLP’ returned 579 results

Use advanced search filters to refine your search

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Trans-Pacific Partnership: Compromise On Biologics Exclusivity Unclear

    Earlier this month, a final agreement was reached on the Trans-Pacific Partnership that could provide for as little as five years of exclusivity for biologics.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
  • Article

    New York Has More To Say About Consumer Data Privacy

    As the national landscape of data privacy laws evolves, New York may be poised to follow California in passing legislation that creates new data rights for New York consumers.
    United StatesPrivacy
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
Article

President-Elect Barack Obama´s Tax Proposals

As President-elect Obama prepares to take office in January, many observers are trying to anticipate the changes that may be made to the federal tax laws.
United StatesTax
Patterson Belknap Webb & Tyler LLP
Patterson Belknap Webb & Tyler LLP
  • Article

    The New York State Sales Tax Net Widens For Sales By Exempt Organizations

    New York law exempts certain types of organizations (such as nonprofit charitable, educational and religious organizations) from the payment of sales tax on their purchases and from the collection of sales tax on certain sales by such organizations.
    United StatesTax
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
  • Article

    Ransomware As Reminder: Back To Basics Of Cyber Readiness

    The growing threat from ransomware is forcing organizations to re-think their cyber risk mitigation strategy. As private organizations and governments look ahead to 2021 and the risks they face in...
    United StatesTechnology
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
  • Article

    Hurricane Sandy - Paths To Relief

    Many small and mid-size businesses in New York City suffered severe losses due to Hurricane Sandy.
    United StatesInsurance
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
  • Article

    Debate Over The Exclusivity Period For Biologics In The Trans-Pacific Partnership

    Under current domestic law, the Affordable Care Act provides 12 years of exclusivity from biosimilar competition for biologic drugs.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
  • Article

    Will The European Court Of Justice Conclude That Antitrust Law Prohibits Royalties For Invalid Patents?

    This case could have important implications for European antitrust law, particularly if the ECJ determines that the EU's antitrust laws must be interpreted as curbing enforcement of private licensing agreements.
    United StatesAntitrust/Competition Law
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
  • Article

    SEC Adopts Rules Requiring Payment Disclosures By Resource Extraction Issuers

    The Securities and Exchange Commission (SEC) recently adopted rules mandated by the Dodd-Frank Wall Street Reform and Consumer Protection Act (Dodd-Frank Act) requiring resource extraction issuers to disclose certain payments made to the U.S. government or to non-U.S. governments.
    United StatesCorporate/Commercial Law
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
  • Article

    EEOC Issues New Enforcement Guidance On The Use Of Criminal Background Checks

    The U.S. Equal Employment Opportunity Commission (EEOC) recently issued new Enforcement Guidance with respect to an employer's consideration ofarrest and conviction records in employment decisions.
    United StatesEmployment and HR
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
  • Article

    DNA Primers: The Trouble With Being Short

    In BRCA1- & BRCA2-Based Hereditary Cancer Test Patent Litig. v. Ambry Genetics Corp. (Ambry), the Federal Circuit invalidated Myriad's claims to short synthetic DNAs.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
  • Article

    Stern Challenge To Third-Party Plan Releases Fails In Delaware

    By the 1990s a degree of stability had been achieved, although maintained, it seemed at times, by paper clips and chewing gum.
    United StatesInsolvency/Bankruptcy/Re-Structuring
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
  • Article

    Adobe Data Breach Ruling Gives New Hope To Plaintiffs

    Data breach class actions have multiplied rapidly in the wake of several sophisticated, large-scale attacks on corporate computer systems.
    United StatesLitigation, Mediation & Arbitration
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
  • Article

    Second Circuit Affirms Mandatory Restitution Award For Bribery Conviction

    In United States v. Razzouk, the Second Circuit (Walker, Carney, Koeltl by designation) considered the meaning of an "offense against property" as used by the Mandatory Victim Restitution Act ("MVRA")
    United StatesCriminal Law
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
  • Article

    Both Parties Seek En Banc Intervention In Amgen v. Sandoz

    Last month, a divided panel of the Federal Circuit issued a split decision in Amgen v. Sandoz (summary; opinion).
    United StatesFood, Drugs, Healthcare, Life Sciences
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
  • Article

    FDA's Proposal For Naming Biosimilars Pleases Some, Disappoints Others

    The Biologics Price Competition and Innovation Act of 2009 (BPCIA) created an abbreviated pathway for the approval of biosimilar biological products, but is silent on how to name them.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
  • Article

    Reminder: Upcoming Health Care Reform Deadlines

    Beginning in 2013, moreover, employee salary reduction contributions to health flexible spending arrangements will be limited to $2,500 per year.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
  • Article

    Bill Proposes Sweeping Changes To Protect Workers In Chapter 11

    On September 29, 2020, the House Judiciary Committee advanced H.R. 7370, Protecting Employees and Retirees in Business Bankruptcies Act of 2020, a Democrat-sponsored bill, to the full chamber.
    United StatesInsolvency/Bankruptcy/Re-Structuring
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
  • Article

    Rough Justice: Third Circuit Issues Important Decision On Unfair Discrimination

    Both § 510(a) and the cramdown provision's unfair discrimination test are concerned with distributions among creditors.
    United StatesInsolvency/Bankruptcy/Re-Structuring
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
  • Article

    If High Court Reverses Teva, Litigation Costs May Increase

    In recent years, the U.S. Supreme Court has shown an increasing willingness to review and, more often than not, reverse, patent law decisions from the Federal Circuit.
    United StatesIntellectual Property
    Patterson Belknap Webb & Tyler LLP
    Patterson Belknap Webb & Tyler LLP
  • Showing 421–440 of 579 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics